| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/23/2000 | CA2342243A1 Stable liquid formulations of botulinum toxin |
| 03/23/2000 | CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders |
| 03/22/2000 | EP0987248A1 Amide derivatives and their therapeutic use |
| 03/22/2000 | EP0986646A1 Ubiquitin conjugation proteins |
| 03/22/2000 | EP0986559A1 1,6-naphthyridine anti-convulsants |
| 03/22/2000 | EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 03/22/2000 | CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells |
| 03/21/2000 | US6040451 Used as analgesic, sedative and anaesthetic agents |
| 03/21/2000 | US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 03/21/2000 | US6040133 D-enzyme compositions and methods of their use |
| 03/16/2000 | WO1999067363A9 Ependymal neural stem cells and method for their isolation |
| 03/16/2000 | CA2341325A1 Method of stimulating prosaposin receptor activity |
| 03/15/2000 | EP0985038A1 Sodium channel receptor |
| 03/15/2000 | EP0984970A1 Spiro-quinuclidine derivatives, their preparation and use |
| 03/15/2000 | EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 03/15/2000 | EP0984943A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 03/15/2000 | CN1247568A Fibroblast growth factor homologs |
| 03/15/2000 | CN1050283C Gel-type cosmetic composite |
| 03/14/2000 | US6037373 Treating nervous system, cytological, hormonal, gastrointestinal and liver disorders |
| 03/14/2000 | US6036954 Polypeptides with sequence |
| 03/09/2000 | WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | WO2000012720A2 Elongase genes and uses thereof |
| 03/09/2000 | WO2000012514A1 Novel compounds |
| 03/09/2000 | WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 03/09/2000 | WO2000011952A1 Compositions and methods for treatment of mitochondrial diseases |
| 03/09/2000 | CA2696878A1 Compositions and methods for treatment of mitochondrial diseases |
| 03/09/2000 | CA2633074A1 Elongase genes and uses thereof |
| 03/09/2000 | CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants |
| 03/08/2000 | EP0983243A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 03/08/2000 | EP0983065A1 Gastric-retained pharmaceutical composition |
| 03/08/2000 | CN1246857A Substituted pyrimidinone and pyridinone compounds and their use |
| 03/08/2000 | CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 03/08/2000 | CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them |
| 03/08/2000 | CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them |
| 03/07/2000 | US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/02/2000 | WO2000011204A2 Homer interacting proteins |
| 03/02/2000 | WO2000011171A2 Human rna-associated proteins |
| 03/02/2000 | WO2000011015A1 Secreted proteins and polynucleotides encoding them |
| 03/02/2000 | WO2000010967A1 Novel aryl sulphonamides and analogues |
| 03/02/2000 | WO2000010545A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 03/02/2000 | WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 03/02/2000 | WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/02/2000 | DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition |
| 03/02/2000 | CA2340928A1 Novel arylsulphonamides and analogues |
| 03/02/2000 | CA2340616A1 Secreted proteins and polynucleotides encoding them |
| 03/02/2000 | CA2340277A1 Human rna-associated proteins |
| 03/01/2000 | EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| 03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 03/01/2000 | EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/01/2000 | EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 03/01/2000 | CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments |
| 03/01/2000 | CN1049817C Method for preparation of percutaneously absorbable drug composition |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000009653A2 Method of inhibiting cathepsin k |
| 02/24/2000 | WO2000009486A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2340092A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2301201A1 Method of inhibiting cathepsin k |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/17/2000 | WO2000007978A1 Aminomethylcarboxylic acid derivatives |
| 02/17/2000 | WO2000007592A1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis |
| 02/17/2000 | WO2000007569A1 Compressed compositions comprising clarified xanthan gum |
| 02/17/2000 | WO2000007565A2 Methods of ophthalmic administration |
| 02/17/2000 | WO1999056784A3 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 02/17/2000 | WO1999015159A3 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | EP0979224A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 02/16/2000 | EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006716A1 Growth differentiation factor-11 |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006142A1 Injectable propofol formulations |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | CA2336536A1 Growth differentiation factor-11 |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335643A1 C7f2-a novel potassium channel .beta.-subunit |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0977892A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000005231A1 Fkbp inhibitors |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004895A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |